Role of acid suppression in acid-related diseases: Proton pump inhibitor and potassium-competitive acid blocker

Hideki Mori, Hidekazu Suzuki

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Proton pump inhibitors are commonly utilized for the treatment of gastric acid-related diseases, such as gastroesophageal reflux disease, peptic ulcer disease, and Helicobacter pylori infection, and for the prevention of low-dose aspirin or nonsteroidal anti-inflammatory drug-induced peptic ulcers. Vonoprazan is a first-in-class potassium-competitive acid blocker, which has distinct advantages compared to other conventional proton pump inhibitors in terms of the efficacy for acid suppression. Due to its strong gastric acid suppression capabilities, vonoprazan serves as an effective drug for the treatment of gastroesophageal reflux disease and H. pylori infection.

Original languageEnglish
Pages (from-to)6-14
Number of pages9
JournalJournal of Neurogastroenterology and Motility
Volume25
Issue number1
DOIs
Publication statusPublished - 2019 Jan 1

Keywords

  • Gastroesophageal reflux
  • Helicobacter pylori
  • Peptic ulcer
  • Potassium
  • Proton pump inhibitors

ASJC Scopus subject areas

  • Clinical Neurology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Role of acid suppression in acid-related diseases: Proton pump inhibitor and potassium-competitive acid blocker'. Together they form a unique fingerprint.

  • Cite this